FDA Licensure of Bivalent Human Papillomavirus Vaccine (HPV2, Cervarix) for Use in Females and Updated HPV Vaccination Recommendations from the Advisory Committee on Immunization Practices (ACIP)
May 28, 2010; 59(20):626-629
www.cdc.gov/mmwr/preview/mmwrhtml/mm5920a4.htm
www.cdc.gov/mmwr/PDF/wk/mm5920.pdf

FDA Licensure of Quadrivalent Human Papillomavirus Vaccine (HPV4, Gardasil) for Use in Males and Guidance from the Advisory Committee on Immunization Practices (ACIP) Weekly
MMWR, May 28, 2010; 59(20):630-632
www.cdc.gov/mmwr/preview/mmwrhtml/mm5920a5.htm
www.cdc.gov/mmwr/PDF/wk/mm5920.pdf

ACIP Recommendations: Quadrivalent Human Papillomavirus Vaccine
MMWR, March 12, 2007; 56(Early Release):1-24
www.cdc.gov/mmwr/preview/mmwrhtml/rr56e312a1.htm?s_cid=rr56e312a1_e
www.cdc.gov/mmwr/pdf/rr/rr56e312.pdf

General Recommendations on Immunization
Source: MMWR, December 1, 2006; 55(RR-15):1-48
www.cdc.gov/mmwr/preview/mmwrhtml/rr5515a1.htm?s_cid=rr5515a1_e
www.cdc.gov/mmwr/PDF/rr/rr5515.pdf
 

American Academy of Pediatrics

Prevention of Human Papillomavirus Infection: Provisional Recommendations for Immunization of Girls and Women with Quadrivalent Human Papillomavirus Vaccine Source: Pediatrics, September 2007; 120(3):666-668 http://pediatrics.aappublications.org/cgi/content/full/120/3/666 http://pediatrics.aappublications.org/cgi/reprint/120/3/666